MS Trial Partnership AIP has partnered with GlobeStar Therapeutics to design and run clinical studies for multiple sclerosis, signaling readiness to engage in end-to-end trial design, imaging endpoints, and regulatory strategy for MS programs.

Nuclear Medicine Synergy With a focus on predictive and personalized healthcare and integrated diagnostic-therapeutic radiopharmaceuticals, AIP is a strong candidate for partnerships in radiopharma manufacturing, dosimetry, and imaging analytics to accelerate development.

Lean Operations AIP operates with a small team, suggesting reliance on external CROs, contract manufacturers, regulatory affairs, and data management partners to scale clinical programs.

US Footprint Based in Surfside, Florida, AIP’s US presence can facilitate access to national clinical networks, regulatory guidance, and collaborations with nearby academic centers and service providers.

Growth Readiness Revenue levels indicate growth potential and openness to milestone-driven engagements, partnerships, or cost-shared models for early-stage radiopharma programs.